Finox Biotech is a member of the Richter Group
home
our locations

history

2016

Satellite Symposium at ESHRE in Helsinki on 3rd July
Richter announces the acquisition of Finox Biotech

2015

Satellite Symposium at ESHRE in Lisbon on 15th June

2014

Satellite Symposium at ESHRE in Munich on 30th June
European Commission Grants Marketing Authorisation for Finox Biotech’s bemfola®
CHMP adopts positive opinion for bemfola for treatment of infertility
Finox Biotech announces first patients enrolled in pivotal US phase III (FIN3002) study for rFSH

2013

Start of US pivotal bemfola study
EMA MAA for bemfola submitted
FIN3001: phase-III Europe primary endpoint achieved

2012

FDA phase-III SPA agreed

2011

Swissmedic establishment licence
Birth of first bemfola baby
Red Dot Design Award injection pen II
MHRA scientific advice
EMA SME status granted

2010

FDA pre-IND meeting
FIN3001: initiation of phase-III in Europe

2009

Red Dot Design Award injection pen I
FIN1001: initiation of phase-I in Europe
AFOLIA pre-clinics completed

2008

EMA scientific advice
ISO 9001 / 13485 certification
AGES scientific advice
API process development realized
r-hFSH cell clone identified

2007

In-licensing r-FSH / bemfola
Company founded

Media

Connect for updates

Finox Biotech is a member of the Richter Group © FINOX AG Burgdorf, Switzerland legal statement privacy policy